洛拉替尼对比伊鲁阿克一线治疗间变性淋巴瘤激酶阳性晚期非小细胞肺癌的成本-效用分析
陈伟伟, 侯艳红, 杨劲, 吴方, 倪雅倩, 刘晶, 刘宇航
Cost-effectiveness analysis of lorlatinib versus iruplinalkib in anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer
CHEN Weiwei, HOU Yanhong, YANG Jin, WU Fang, NI Yaqian, LIU Jing, LIU Yuhang
中国医院药学杂志
.
2026, (3): 301
-306
.
DOI: 10.13286/j.1001-5213.2026.03.09
